Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$360M |
| 2 |
Lam Research
LRCX
|
+$310M |
| 3 |
Medtronic
MDT
|
+$281M |
| 4 |
Cigna
CI
|
+$234M |
| 5 |
Qualcomm
QCOM
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$575M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$461M |
| 3 |
UnitedHealth
UNH
|
+$445M |
| 4 |
Johnson & Johnson
JNJ
|
+$411M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.38% |
| 2 | Healthcare | 11.34% |
| 3 | Financials | 10.59% |
| 4 | Industrials | 8.59% |
| 5 | Consumer Discretionary | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
1stdibs.com
DIBS
$147M
| $51K | ﹤0.01% |
+12,849
| New | +$65.3K |
|
|
SACH
3802
Sachem Capital Corp
SACH
$38.6M
| $50.2K | ﹤0.01% |
13,500
-5,000
| -27% | -$18.4K |
|
3803
CEMIG Preferred Shares
CIG
$6.21B
| $49.3K | ﹤0.01% |
28,558
| – | – |
|
3804
Ardelyx
ARDX
$1.25B
| $48.9K | ﹤0.01% |
+10,213
| New | +$34.4K |
|
3805
Precigen
PGEN
$2.12B
| $48.1K | ﹤0.01% |
+45,349
| New | +$65.4K |
|
|
SGMO
3806
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $46.5K | ﹤0.01% |
26,437
-42,636
| -62% | -$122K |
|
|
MGF
3807
Aberdeen Government Markets Income Fund
MGF
$91.6M
| $46.2K | ﹤0.01% |
+14,000
| New | +$46.6K |
|
3808
Workhorse Group
WKHS
$34.5M
| $44.9K | ﹤0.01% |
11
| – | – |
|
|
TELL
3809
DELISTED
Tellurian Inc.
TELL
| $44.3K | ﹤0.01% |
35,992
+3,228
| +10% | +$5.14K |
|
|
CMLS
3810
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $44.1K | ﹤0.01% |
11,964
| – | – |
|
|
KG
3811
Kestrel Group
KG
$67.1M
| $40.9K | ﹤0.01% |
+979
| New | +$45.4K |
|
|
DBD
3812
DELISTED
Diebold Nixdorf Incorporated
DBD
| $38.8K | ﹤0.01% |
32,333
+16,788
| +108% | +$37.3K |
|
3813
Lineage Cell Therapeutics
LCTX
$277M
| $38.5K | ﹤0.01% |
25,674
+14
| +0.1% | +$20 |
|
3814
Mizuho Financial
MFG
$126B
| $38.1K | ﹤0.01% |
+13,510
| New | +$41.3K |
|
|
NKLA
3815
DELISTED
Nikola Corporation Common Stock
NKLA
| $38K | ﹤0.01% |
1,047
-43
| -4% | -$2.82K |
|
3816
CEL-SCI Corp
CVM
$21.3M
| $37.5K | ﹤0.01% |
538
+4
| +0.7% | +$313 |
|
3817
Barnes & Noble Education
BNED
$430M
| $36.2K | ﹤0.01% |
+238
| New | +$47.9K |
|
|
AHT
3818
Ashford Hospitality Trust
AHT
$20.9M
| $35.2K | ﹤0.01% |
+1,097
| New | +$54.9K |
|
3819
Bioventus
BVS
$893M
| $34.7K | ﹤0.01% |
+32,457
| New | +$62.1K |
|
3820
Ondas Inc
ONDS
$4.32B
| $31.9K | ﹤0.01% |
29,570
-2,501
| -8% | -$4.35K |
|
3821
Erasca
ERAS
$6.48B
| $30.6K | ﹤0.01% |
+10,175
| New | +$37K |
|
|
LONA
3822
LeonaBio Inc
LONA
$68.5M
| $29.1K | ﹤0.01% |
1,164
-2,291
| -66% | -$73.8K |
|
|
AMRS
3823
DELISTED
Amyris Inc.
AMRS
| $27.3K | ﹤0.01% |
20,043
-1,848
| -8% | -$2.64K |
|
|
CASA
3824
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $26.7K | ﹤0.01% |
20,988
-1,429,426
| -99% | -$4.35M |
|
3825
Senseonics Holdings Inc
SENS
$265M
| $26.3K | ﹤0.01% |
1,855
-1
| -0.1% | -$20 |
|
Similar funds
Ameriprise's Q1 2023 Portfolio in Review
As of Q1 2023, Ameriprise held 4,099 positions worth $305B, up 4.5% from $292B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q1 2023 filing shows 180 new, 1,847 increased, 1,770 reduced and 165 closed positions. Its largest new stake was GE HealthCare: 1,934,385 shares worth $159M. The largest sale was US Bancorp, an estimated $575M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q1 2023 buy was GE HealthCare: 1,934,385 shares worth $159M.
- Ameriprise added most to Walmart Inc in Q1 2023, an estimated $360M increase.
- Ameriprise's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $575M.
- Ameriprise fully exited SVB Financial Group in Q1 2023, selling an estimated $201M.
- Ameriprise's ten largest holdings make up 14% of its $305B portfolio in Q1 2023.
- Ameriprise opened 180 new positions and closed 165 in Q1 2023.
- Ameriprise's portfolio value rose 4.5% quarter-over-quarter to $305B.
Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.